www.ijcem.com /ISSN:1940-5901/IJCEM0011546
Original Article
Comparison of Vitamin D levels in cases with
preeclampsia, eclampsia and healthy pregnant women
Murat Bakacak1, Salih Serin1, Onder Ercan1, Blent Kst1, Fazl Avci1, Metin Kln2, Hakan Kran1, Grkan
Kiran1
Department of Obstetrics and Gynecology, School of Medicine, Kahramanmaras Sutcu Imam University,
Kahramanmara, Turkey; 2Department of Biochemistry,School of Medicine, Kahramanmaras Sutcu Imam University, Kahramanmara, Turkey
1
Received June 17, 2015; Accepted August 5, 2015; Epub September 15, 2015; Published September 30, 2015
Abstract: The aim of this study is to assess vitamin D levels in eclampsia, preeclampsia and healthy pregnant women and the role of vitamin D deficiency in the etiology of preeclampsia (PE). Forty healthy pregnant women, 83 preeclamptic and 32 eclamptic pregnant women were included. Maternal and infant medical records were reviewed.
Blood samples were obtained from all groups. Demographics and serum vitamin D levels were compared between
the groups. No statistical differences were observed in age, gravidity, parity, weight, height and BMI between the
three groups. Week of pregnancy and weight at birth in eclamptic and preeclamptic patients were lower compared
to the healthy patients (P<0.001 and P<0.001, respectively). Systolic and diastolic blood pressures were higher in
eclamptic (P<0.001) and preeclamptic patients (P<0.001) compared to the healthy pregnant group. The rate of
cesarean section was found to be higher in preeclamptic and eclamptic patients (P<0.001). Vitamin D levels were
lower in both preeclamptic and eclamptic patients compared to healthy normotensive pregnant women (P<0.001).
Preeclamptic and eclamptic women were similar in terms of the data compared. Vitamin D supplementation is
considered to decrease the risk of both preeclampsia and eclampsia in the patient population at risk for vitamin D
deficiency.
Keywords: Vitamin D, preeclampsia, eclampsia, hypertension, 25-hydroxy vitamin D
Introduction
Preeclampsia (PE) is a disease specific to pregnancy, affecting many bodily systems, characterized by high blood pressure and proteinuria
after the 20th week of pregnancy, complicating
2-8% of pregnancies and increasing maternal
and fetal mortality and morbidity [1-3]. Multiple factors, such as maternal constitutional
factors, angiogenetic factors, endothelial dysfunction, syncytiotrophoblastic microparticles
(STMP), and inflammatory activation, play a role
in the development and progression of preeclampsia [4]. The maternal diet is among the
factors related to the etiology of preeclampsia;
an insufficient diet, especially in terms of calcium, magnesium, selenium and vitamin A and C,
is a contributing factor to preeclampsia [5, 6].
Recent epidemiological studies have emphasized the role of vitamin D deficiency in the
Production of vitamin D in the decidua, placenta and the maternal kidneys increases during
pregnancy [17]. Since vitamin D level is dependent on the exposure of sunlight, vitamin D support and dietary factors, there will be little or no
change in the level of vitamin D during pregnancy [18]. In recent studies carried out in the USA,
Australia, the Middle East and South Asia, vitamin D deficiency was detected in 26-98% of
pregnant women. Vitamin D deficiency is
around 66-100% in women with a dark skin
color [19-21]. When defining the level of vitamin
D in the serum, though not standard, the cut-off
level for vitamin D deficiency is acceptable at
20 ng/ml in the latest studies, although previously it was accepted at 15 ng/ml [22, 23].
Based on the literature, establishing the relationship between preeclampsia and vitamin D
is complicated [24-26]. There are various studies on the role of vitamin D on the development
and pathophysiology of preeclampsia and eclampsia. A low vitamin D level in the second trimester has been emphasized in previous studies to be an indicator of preeclampsia [25, 27].
Many studies have supported the hypothesis of
the role of vitamin D in the etiology of preeclampsia and eclampsia. Studies have pointed out different ways vitamin D plays a role in
the etiology of preeclampsia.
Vitamin D has been thought to play a potent
endocrine suppressor role in renin biosynthesis
for the regulation of the renin-angiotensin system (RAS). In addition, hypertension is suggested to be tied to preeclampsia and eclampsia
[15].
In addition, in other studies on the role of vitamin D in the development of preeclampsia,
vitamin D has been emphasized to play an
immunomodulatory and anti-inflammatory role
in many systems [28]. Vitamin D also has been
suggested to play a role in major signal and
gene regulations in the development of placental trophoblasts in the placental growth phase
Int J Clin Exp Med 2015;8(9):16280-16286
P Value
NS
NS
NS
NS
NS
NS
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
One-way ANOVA Test (Brown-Forsythe) Post Hoc Test: LSD-Games Howell; Kruskal Wallis Test Post Hoc Test: nonparametric posthoc test (Miller, 1966); Pearson Chi Square Test (Monte Carlo)-Mann-Whitney U Test. n (%); *Mean SD (standard deviation);
**Median Range (Maximum-Minimum); P<0.001 Significant based on Healthy Pregnant Group.
16284
(mean serum 25(OH)D3 21.56 ng/ml). Vitamin D supplementation has been shown to
decrease the risks of both preeclampsia and
eclampsia in the patient population at risk for
vitamin D deficiency [15]. Our study also
revealed that the vitamin D levels were significantly lower in patients with PE and eclampsia
compared to the healthy pregnant women. In
addition, our study revealed that vitamin D levels were similar in the PE and eclamptic groups.
In conclusion, although several studies have
reported to the contrary, our study demonstrates that vitamin D plays a role in the etiology and pathophysiology of preeclampsia. In
populations in the risk group of vitamin D deficiency, the risk of hypertensive pregnancy diseases may be decreased through vitamin D
support. Our study also suggests that vitamin D
support in patients with a history of preeclampsia in previous pregnancies may decrease the
risk of preeclampsia and eclampsia during the
current pregnancy.
Disclosure of conflict of interest
None.
Address correspondence to: Murat Bakacak, Kahramanmaras Sutcu Imam Universitesi, Tp Fakltesi,
Avsar Kampusu, Merkez, Kahramanmaras, Turkey.
Tel: 00903442803739; Fax: 00903442803738;
E-mail: muratbakacak46@gmail.com
References
[1]
[2]
[3]
[4]
[5]
[6]
Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet 2010; 376:
631-44.
Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005; 365: 785-99.
James JL, Whitley GS, Cartwright JE. Preeclampsia: fitting together the placental, immune and cardiovascular pieces. J Pathol
2010; 221: 363-78.
Roberts JM, Hubel CA. The two-stage model of
preeclampsia: variations on the theme. Placenta 2009; 30 Suppl A: S32-7.
Homfmyer GJ, Duley L, Atallah A. Dietary calcium supplementation for prevention of preeclampsia and related problems: a systematic
review and commentary. BJOG 2007; 114:
933-943.
Wallis AB, Saftlas AF. A gram of prevention: a
modest increase in fiber consumption may reduce risk of preeclampsia. Am J Hypertens
2008; 21: 849-50.
[8]
[9]
[10]
[11]
[12]
[13]
[14]
[15]
[16]
[17]
[18]
Wei S, Audibert F, Hidiroglou N, Sarafin K, Julien P, Wu Y, Luo ZC, Fraser WD. Longitudinal
vitamin D status in pregnancy and the risk of
pre-eclampsia. BJOG 2012; 119: 832-9.
Grundmann M, Haidar M, Placzko S, Niendorf
R, Darashchonak N, Hubel CA, von VersenHynck F. Vitamin D improves the angiogenic
properties of endothelial progenitor cells. Am J
Physiol Cell Physiol 2012; 303: C954-62.
Kudo K, Hasegawa S, Suzuki Y, Hirano R, Wakiguchi H, Kittaka S, Ichiyama T. 1,25-Dihydroxyvitamin D(3) inhibits vascular cellular adhesion molecule-1 expression and interleukin-8 production in human coronary arterial
endothelial cells. J Steroid Biochem Mol Biol
2012; 132: 290-4.
Fischer D, Schroer A, Ludders D, Cordes T,
Bcker B, Reichrath J, Friedrich M. Metabolism
of vitamin D3 in the placental tissue of normal
and preeclampsia complicated pregnancies
and premature births. Clin Exp Obstet Gynecol
2007; 34: 80-4.
Novakovic B, Sibson M, Ng HK, Manuelpillai U,
Rakyan V, Down T, Beck S, Fournier T, EvainBrion D, Dimitriadis E, Craig JM, Morley R, Saffery R. Placenta-specific methylation of the vitamin D 24-hydroxylase gene: implications for
feedback autoregulation of active vitamin D
levels at the fetomaternal interface. J Biol
Chem 2009; 284: 14838-48.
Diaz L, Noyola-Martinez N, Barrera D, Hernndez G, Avila E, Halhali A, Larrea F. Calcitriol inhibits TNF-alpha-induced inflammatory cytokines in human trophoblasts. J Reprod Immunol 2009; 81: 17-24.
World Health Organization. WHO recommendations for prevention and treatment of preeclampsia and eclampsia. Geneva: World
Health Organization; 2011.
Snydal S. Major Changes in Diagnosis and
Management of Preeclampsia. J Midwifery Womens Health 2014; 59: 596-605.
Ullah MI, Koch CA, Tamanna S, Rouf S, Shamsuddin L. Vitamin D deficiency and the risk of
preeclampsia and eclampsia in Bangladesh.
Horm Metab Res 2013; 45: 682-7.
Huppertz B. Placental origins of preeclampsia
challenging the current hypothesis. Hypertension 2008; 51: 970-975.
Prez-Lpez FR. Vitamin D: the secosteroid
hormone and human reproduction. Gynecological Endocrinology 2007; 23: 13-24.
Fernndez-Alonso AM, Dionis-Snchez EC,
Chedraui P, Gonzlez-Salmern MD, PrezLpez FR; Spanish Vitamin D and Womens
Health Research Group. First-trimester maternal serum 25-hydroxyvitamin D3 status and
pregnancy outcome. Int J Gynaecol Obstet
2012; 116: 6-9.
16285
16286